Comparison of equivalence and determination of diagnostic utility of Min-Mod and Clamp methods for insulin resistance in diabetes free subjects: A meta-analysis
Article
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
The gold standard for quantifying insulin sensitivity (IS) is the hyperinsulinemic-euglycemic clamp (Clamp) with a cut-off point of 5 × 10 -2 (dL/min)/(μU/mL) or less to indicate insulin resistance. Bergman's minimal model (Min-Mod) is also being used to estimate IS, but there are doubts as to its equivalence with Clamp. The objective of the present study is to determine if Clamp and the tolbutamide and insulin techniques of Min-Mod are equivalent. Meta-analysis based on a bibliographic search from 1970 until the present was made for the MeSH terms: insulin resistance, hyperglycemic-clamp, euglycemic-clamp, Min-Mod, minimal model approach. Concordance was determined with both simple and intraclass correlation and Bland and Altman's concordance limits using R. Three of the 109 articles found were included. The concordance limits indicate that Clamp and Min-Mod are not equivalent, which could result in diagnostic errors if the accepted cut-off point is used for both methods. Given this lack of equivalence, a ROC analysis was performed and new diagnostic cut-off points of 2.4 and 4.6 × 10 -2 (dL/ min)/(μU/mL) for insulin and tolbutamide techniques of Min-Mod, respectively, are proposed, with adequate sensitivity, specificity, and predictive value. These values should be prospectively validated. © 2004 by Humana Press Inc. All rights of any nature whatsoever reserved.
publication date
published in
Research
keywords
Clamp; Insulin resistance; Measurements; Meta-analysis; Minimal model tolbutamide; antidiabetic agent; diagnostic agent; glucose; insulin; article; bibliographic database; comparative study; correlation analysis; diabetes mellitus; diagnostic error; glucose clamp technique; human; insulin resistance; insulin sensitivity; intermethod comparison; prediction; priority journal; receiver operating characteristic; sensitivity and specificity; blood; clinical trial; diabetes mellitus; glucose blood level; glucose tolerance test; meta analysis; metabolism; methodology; physiology; reproducibility; review; roc curve; standard; Blood Glucose; Diabetes Mellitus; Glucose; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tolbutamide
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue